Drug Doubles Survival Time - Saltikva

Posted by layla97 @layla97, Nov 23, 2023

Anyone know how to obtain the drug Saltikva which earned fast-track FDA approval in Jan 2022. Studies have shown the Salmonella IL2 drug Saltikva doubled survival time for Stage IV pancreatic cancer which is why it was fast-tracked for approval by the FDA. It is administered orally in combination with Folfirinox every 2 weeks. You would think a cancer hospital specialty like The Mayo Clinic, or Sloane-Kettering in NYC would offer this. My sister was diagnosed in July and has had 5 infusions of Folfirinox. I am an NP and discovered this online while looking for additional drugs for this purpose.

Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.

maggie797 | @maggie797 | Dec 26, 2023

Update : I emailed directly the doctors in charge of the McGill university study since I live in Quebec City (not so far). They told me the study was closed and that there was no access to the saltikva drug. They also told me that the company would get into phase 3 study in the future.

I'm a little confused since some people in this group had a positive response from Salspera and expended access...

I'm telling myself that at least they gave me an answer...

layla97 | @layla97 | Jan 5 8:42am

In reply to @ncteacher "@altc321 , thank you for posting this. It does look very encouraging. I'm going to print..." + (show)

Hi, I am curious to know if you presented this to your oncologist and what his response was.
Thanks!

ncteacher | @ncteacher | Jan 5 8:54am

In reply to @layla97 "Hi, I am curious to know if you presented this to your oncologist and what his..." + (show)

I mentioned Saltikva at our previous meeting (12/21) and he said he hadn't heard anything about it. He made a note of it and planned to do some reading. Then I forgot to inquire about it at our meeting yesterday, and he didn't mention it either. To be honest, my cancer is responding so well to the Folfiri right now that we're not looking for alternative therapies (yet).

Anyway, here's something else that might be of interest. My MD said that he'll be attending the ASCO gastrointestinal cancers conference 1/18-20, and he often picks up anecdotal info on various issues and treatments that he can consider for his clinical practice. He said if I'm curious about possible advances or treatment options, I might look at the ASCO site. I just did a Google search and saw that they've posted 753 (!) abstracts on research to be presented at the conference. Not all of them are on pancan, but there might be something interesting in there. I don't mean to imply that Saltikva is on this list; I don't know that it is, just that there might be something of interest regarding pancan.

View More View Less

Please sign in or register to post a reply.